ArriVent BioPharma Inc. Common Stock (AVBP) Revenue Analysis | Historical Sales Growth & Trends - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ArriVent BioPharma Inc. C...

    NASDAQ: AVBP · Real-Time Price · USD
    19.84
    1.01 (5.36%)
    At close: Oct 03, 2025, 3:59 PM
    19.84
    0.00%
    After-hours: Oct 03, 2025, 04:04 PM EDT

    ArriVent BioPharma Common Stock Revenue

    ArriVent BioPharma Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, ArriVent BioPharma Common Stock generated $0 in revenue.
    Revenue (ttm)
    0
    Revenue Growth
    n/a
    Price / Sales Ratio
    0
    Revenue / Employee
    0
    Employees
    52
    Market Cap
    804.89M

    Revenue Chart

    History

    Fiscal Year End Revenue % Change
    Dec 31, 2024 0 n/a
    Dec 31, 2023 0 n/a
    Dec 31, 2022 0 n/a
    Dec 31, 2021 0 n/a
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist